Tony Coles.
Co-founder of Onyx Pharmaceuticals
He developed targeted therapies for cancer treatment.
His work transformed the biotech industry and patient care.
In 1958, he was born in the USA.
In 1982, he earned his MD from Yale University.
In 1992, he co-founded Onyx Pharmaceuticals.
1. Onyx Pharmaceuticals, a biotech company creating targeted cancer therapies.
2. It develops drugs for blood cancers and solid tumors.
3. It supports clinical trials and innovative cancer treatments.
His leadership advanced biotech innovation worldwide.
He continues to mentor and guide biotech ventures.
He currently serves as CEO of Cerevel Therapeutics and advisor in biotech.
Want to know more stories?
Visit Tony Coles.